Akari Therapeutics Stock Forecast - Accumulation Distribution

AKTX Stock  USD 1.30  0.06  4.84%   
Akari Stock Forecast is based on your current time horizon.
  
Inventory Turnover is likely to drop to -0.0014 in 2024. Payables Turnover is likely to drop to 0 in 2024. Common Stock Shares Outstanding is likely to drop to about 4.7 M in 2024. Net Loss is likely to drop to about (21 M) in 2024.
On November 14, 2024 Akari Therapeutics PLC had Accumulation Distribution of 399.78. The accumulation distribution (A/D) indicator shows the degree to which Akari Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Akari Therapeutics PLC to determine if accumulation or reduction is taking place in the market. This value is adjusted by Akari Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Akari Therapeutics VolatilityBacktest Akari TherapeuticsTrend Details  

Akari Therapeutics Trading Date Momentum

On November 15 2024 Akari Therapeutics PLC was traded for  2.08  at the closing time. The top price for the day was 2.17  and the lowest listed price was  1.77 . The trading volume for the day was 19.4 K. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 6.73% . The overall trading delta against the current closing price is 9.87% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Akari Therapeutics to competition

Other Forecasting Options for Akari Therapeutics

For every potential investor in Akari, whether a beginner or expert, Akari Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Akari Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Akari. Basic forecasting techniques help filter out the noise by identifying Akari Therapeutics' price trends.

Akari Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akari Therapeutics stock to make a market-neutral strategy. Peer analysis of Akari Therapeutics could also be used in its relative valuation, which is a method of valuing Akari Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Akari Therapeutics PLC Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Akari Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Akari Therapeutics' current price.

Akari Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Akari Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Akari Therapeutics shares will generate the highest return on investment. By undertsting and applying Akari Therapeutics stock market strength indicators, traders can identify Akari Therapeutics PLC entry and exit signals to maximize returns.

Akari Therapeutics Risk Indicators

The analysis of Akari Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Akari Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting akari stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Akari Stock Analysis

When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.